Key facts
- This page summarizes Alexandra Balcom's Form 4 filing for Nuvalent, Inc. (NUVL).
- 14 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 19 Nov 2025, 17:14.
Alexandra Balcom - 17 Nov 2025 Form 4 Insider Report for Nuvalent, Inc. (NUVL)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- NUVL
- Reported as of
- 17 Nov 2025
- Net transaction value
- -$1,015,325
- SEC form
- 4
- Accepted by SEC
- 19 Nov 2025, 17:14:13 UTC
- Prior SEC filing
- 17 Oct 2025
- Next SEC filing
- 10 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nathan N. McConarty, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Alexandra Balcom filed Form 4 for Nuvalent, Inc. (NUVL) on 19 Nov 2025.
Change
- Previous filing in this sequence was filed on 17 Oct 2025.
- Current net transaction value: -$1,015,325.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001862147
Primary reporting owner
Balcom Alexandra
- Relationship
- Chief Financial Officer
- Address
- C/O NUVALENT, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
- Signature
- /s/ Nathan N. McConarty, attorney-in-fact
- Signature date
- 19 Nov 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NUVL
transaction
Class A Common Stock
Options Exercise
- Transaction value
- $47,369
- Shares
- +6,875
- Change %
- +11%
- Price
- $6.89
- Shares after
- 68,609
- Date
- 17 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
NUVL
transaction
Class A Common Stock
Options Exercise
- Transaction value
- $949,594
- Shares
- +13,125
- Change %
- +19%
- Price
- $72.35
- Shares after
- 81,734
- Date
- 17 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
NUVL
transaction
Class A Common Stock
Sale
- Transaction value
- $338,524
- Shares
- -3,609
- Change %
- -4.4%
- Price
- $93.80
- Shares after
- 78,125
- Date
- 17 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F2
NUVL
transaction
Class A Common Stock
Sale
- Transaction value
- $310,662
- Shares
- -3,266
- Change %
- -4.2%
- Price
- $95.12
- Shares after
- 74,859
- Date
- 17 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F3
NUVL
transaction
Class A Common Stock
Sale
- Transaction value
- $452,208
- Shares
- -4,496
- Change %
- -6%
- Price
- $100.58
- Shares after
- 70,363
- Date
- 17 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F4
NUVL
transaction
Class A Common Stock
Sale
- Transaction value
- $326,203
- Shares
- -3,194
- Change %
- -4.5%
- Price
- $102.13
- Shares after
- 67,169
- Date
- 17 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F5
NUVL
transaction
Class A Common Stock
Sale
- Transaction value
- $522,030
- Shares
- -5,055
- Change %
- -7.5%
- Price
- $103.27
- Shares after
- 62,114
- Date
- 17 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F6
NUVL
transaction
Class A Common Stock
Sale
- Transaction value
- $39,398
- Shares
- -380
- Change %
- -0.61%
- Price
- $103.68
- Shares after
- 61,734
- Date
- 17 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F7
NUVL
transaction
Class A Common Stock
Options Exercise
- Transaction value
- $52,743
- Shares
- +729
- Change %
- +1.2%
- Price
- $72.35
- Shares after
- 62,463
- Date
- 18 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
NUVL
transaction
Class A Common Stock
Sale
- Transaction value
- $22,794
- Shares
- -220
- Change %
- -0.35%
- Price
- $103.61
- Shares after
- 62,243
- Date
- 18 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F8
NUVL
transaction
Class A Common Stock
Sale
- Transaction value
- $53,211
- Shares
- -509
- Change %
- -0.82%
- Price
- $104.54
- Shares after
- 61,734
- Date
- 18 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F9
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NUVL
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -6,875
- Change %
- -19%
- Price
- $0.000000
- Shares after
- 29,101
- Date
- 17 Nov 2025
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 6,875
- Exercise price
- $6.89
- Footnotes
- F1, F10
NUVL
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -13,125
- Change %
- -28%
- Price
- $0.000000
- Shares after
- 34,375
- Date
- 17 Nov 2025
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 13,125
- Exercise price
- $72.35
- Footnotes
- F1, F11
NUVL
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -729
- Change %
- -2.1%
- Price
- $0.000000
- Shares after
- 33,646
- Date
- 18 Nov 2025
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 729
- Exercise price
- $72.35
- Footnotes
- F1, F11
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 11 footnotes
Footnote F1
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024.
Footnote F2
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.73 to $94.38, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (9) of this Form 4.
Footnote F3
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.93 to $95.58, inclusive.
Footnote F4
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.11 to $101.07, inclusive.
Footnote F5
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.57 to $102.47, inclusive.
Footnote F6
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.60 to $103.54, inclusive.
Footnote F7
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.65 to $103.79, inclusive.
Footnote F8
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.14 to $103.96, inclusive.
Footnote F9
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.25 to $105.12, inclusive.
Footnote F10
The shares underlying this option vest as follows: 25% of the shares vested on April 29, 2022, and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
Footnote F11
The shares underlying this option have vested or shall vest over the four years following January 5, 2024 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.